FDA

Latest News

© The 2R Artificiality - stock.adobe.com
FDA Approves Gomekli, First and Only NF1-PN Treatment for Both Children and Adults

February 14th 2025

Gomekli is the second ever FDA-approved treatment for rare tumor disease, NF1-PN and the first to be approved for both adult and pediatric patients.

FDA Approves Expanded Label for Izervay, No Dosing Duration Limit
FDA Approves Expanded Label for Izervay, No Dosing Duration Limit

February 13th 2025

 LELISAT-stock.adobe.com
FDA Sets Review Date for Linvoseltamab for Multiple Myeloma

February 11th 2025

AGPhotography-stock.adobe.com
FDA Approves Combination Antibiotic for Complicated Infections

February 10th 2025

 yodiyim-stock.adobe.com
FDA Sets Review Date for Chronic Lung Disease Therapy

February 7th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.